April 2001
H&HN: Hospitals & Health Networks;Apr2001, Vol. 75 Issue 4, p79
Trade Publication
Presents news briefs on the health care sector in the United States as of April 2001. Response of Afro-Americans to hepatitis C treatments ; Medical techniques in helping children in pain from surgery, chronic illness or routine vaccinations; Medical care services received by uninsured people in the U.S.


Related Articles

  • It's in the mix: HIV and hepatitis C services in small jurisdictions. Marriott, Kevin // HIV Australia;2008, Vol. 8 Issue 1, p25 

    The article reports on the experience of the Tasmanian Council on AIDS, Hepatitis and Related Disease (TasCAHRD) in providing community-based education and support services to people with hepatitis C and HIV infections. It discusses the issue on the preparedness of these people to access...

  • Peginterferon-α-2a better option for hepatitis C in Brazil.  // PharmacoEconomics & Outcomes News;11/2/2013, Issue 690, p9 

    The article cites a study conducted in Brazil which appeared in an article by FMR Barros et al. in the October 8, 2013 issue of "Cost Effectiveness and Resource Allocation," showing that peginterferon-a-2a is more effective and less costly than peginterferon-a-2b in treating chronic hepatitis C.

  • ECHO model effectively improved access to care for HCV in underserved populations. DeNyse, Ashley // Infectious Disease News;Jul2011, Vol. 24 Issue 7, p12 

    The article discusses the effectiveness of the Extension for Community Healthcare Outcomes model in managing hepatitis C infection in rural and underserved communities in the U.S.

  • Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements. Grebely, Jason; Matthews, Gail V.; Lloyd, Andrew R.; Dore, Gregory J. // Clinical Infectious Diseases;Oct2013, Vol. 57 Issue 7, p1014 

    Modeling studies suggest that modest increases in hepatitis C virus (HCV) treatment could lead to substantial reductions in HCV prevalence among people who inject drugs. This article focuses on issues to consider for the feasibility of HCV treatment as prevention.The demonstration that...

  • Effect of Previous Interferon Treatment on Outcome After Curative Treatment for Hepatitis C Virus-Related Hepatocellular Carcinoma. Miyatake, Hirokazu; Kobayashi, Yoshiyuki; Iwasaki, Yoshiaki; Nakamura, Shin-ichiro; Ohnishi, Hideki; Kuwaki, Kenji; Toshimori, Junichi; Hagihara, Hiroaki; Nouso, Kazuhiro; Yamamoto, Kazuhide // Digestive Diseases & Sciences;Apr2012, Vol. 57 Issue 4, p1092 

    Background and Aims: Treatment of chronic hepatitis C virus (HCV) infection with interferon (IFN) prevents the development of hepatocellular carcinoma (HCC). The purpose of this study was to clarify the effect of previous IFN treatment before the development of HCC on recurrence and survival in...

  • Viral hepatitis C management involves some tough decisions. Iizuka, Izabella // Managed Healthcare Executive;Feb2006, Vol. 16 Issue 2, p38 

    The article reports several issues regarding the treatment of viral hepatitis C virus (HCV). the identification and treatment of patients with the hepatitis C virus is a complicated and difficult process. It is expected that high cost of treating patients with HCV will become a burden on the...

  • Hepatitis C containing an invisible epidemic. D'Epiro, Nancy Walsh // Patient Care;10/15/1998, Vol. 32 Issue 16, p96 

    Looks at the methods used to control and prevent Hepatitis C in the United States. Estimated number of Americans affected with the disease; Improvement to treatment possibilities in this disease; Advice offered to primary care physicians regarding the treatment of the disease; Reference to a...

  • Random effect model for identifying related factors to virological response in HCV patients. Zayeri, Farid; Chaibakhsh, Samira; Pourhoseingholi, Asma; Akbarzadeh Baghban, Alireza; Moayed Alavian, Seyed // Gastroenterology & Hepatology from Bed to Bench;Supplement 1, Vol. 6, pS65 

    Aim: This study aims to employ random effect model to evaluate prognostic factors of hepatitis C. Background: In recent years, hepatitis C virus (HCV) infection has been a major cause of liver diseases worldwide and represents a major public health problem. Evaluation of risk factors and a...

  • An audit of hepatitis C service provision in a representative sample of prisons in England. Humphreys, Clare; Railton, Cathie; O'Moore, Éamonn; Lombard, Martin; Newton, Autilia // Journal of Public Health;Mar2015, Vol. 37 Issue 1, p151 

    Background Prisons are an important setting to address prevention, testing and treatment of hepatitis C virus (HCV) and other blood-borne viruses. This audit examined current practice against national standards in a representative sample of prisons in England. Methods The audit tool was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics